$9.40
−7.14 (−43.17%)Oct 30, 2026, 8:00 PM ET
Market Closed
WSL TV Briefing
PELTHOS THERAPEUTICS INC. (PTHS)Biotechnology● WSL TV
PTHSBiotechnology
WALLSTLEDGER TVOpening
Pelthos Therapeutics Inc.: Company Briefing
Biotechnology · Healthcare
MARKET SNAPSHOT
Open18.72
High20.50
Low9.02
Prev. close16.54
Volume241.2K
52-week range9.02 – 37.50
BUSINESS FOCUSBiotechnology
PTHS
KEY DRIVERS
◈ Revenue growth
◈ Profit margins
◈ Healthcare sector trends
WHAT TO WATCH
▣ Next earnings report
▣ Guidance
▣ SEC filings
MARKET BRIEFINGPelthos Therapeutics Inc. · Biotechnology · 9.40 (−43.17%)
0:00 / 1:30
Company Overview
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
Key Highlights
- Biotechnology · Healthcare
- Led by Scott Plesha
- 92 employees
- Based in Durham, NC
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 2
ISM Manufacturing PMI
10:00 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
77,363 −0.31%
Ethereum (ETH)
2,243 +0.96%
Solana (SOL)
95 −1.39%
Stock Quote
View Full Quote →AMEX:PTHS
Pelthos Therapeutics Inc.
$9.40
−7.14 (−43.17%)- Day Range
- $9.02 – $20.50
- 52 Week Range
- 9.02-37.5
- Volume
- 241,198
- Avg. Volume
- 56,043
- Market Cap
- 36M
- Shares Outstanding
- —
Market data delayed by 15 minutes.
Company Facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Durham, NC, US
- Incorporated
- Feb 16, 2024
- Website